|Event Date/Time: May 18, 2009||End Date/Time: May 20, 2009|
increasingly becoming a favored destination for clinical trials, a gap analysis needs to be
done to scale up all resources for clinical trials. This scale up is essential for India to cope
with the large global clinical trial projects. It is no coincidence over the last decade or
more of economic liberalization, and years of unprecedented growth, that India and parts
of South Asia are becoming a preferred clinical research destination for multinational
pharmaceutical and biotechnology corporations. Clinical Trials Summit in Asia 2009 will discuss the on-going pressing concerns faced in
clinical trials operations, addressing the risks, timeline and budget constraint, whilst effectively
tackling key challenges in overcoming trials agreement and site contract negotiation hurdles. This year, the operational element of trial site management, strategic partnership with
CROs and SMOs, patient, talent & investigators management will be discussed in order to
improve and optimize the overall drug development effectiveness and ROI. Find out how to
implement and benefi t from electronic data management & monitoring cost effectively. This
event will be shared by leading industrial practitioners across the region to promote practical
discussions; especially on the know-how to manage needs, variability of different countries
and institutions to enhance clinical operational excellence and vigilance. Delegates will have
the opportunity to learn, network and benchmark against the global top pharmas and local
industry leaders on the best practices in talent, site, budget and performance management in
clinical trials. The conference aims to provide a detailed analysis of what it takes to conduct
clinical trials from a biopharmaceuticals and vaccines perspective in India and China and also
addressing risk/benefi t balance, anecdotal experiences of the multinational pharmaceutical
industry in India and China, selection and role of CROs, logistics of operations, clinical trials
management, government policies (including IPR issues) and pharmacovigilance.
It gives me immense pleasure in welcoming you to the Clinical Trials Summit in Asia â€™2009.
Reasons to register today:
â€¢ How can you take advantage of the global market for clinical trials?
â€¢ Improving and optimizing site management and overall productivity of clinical operations
â€¢ Optimising clinical trials operation effectiveness and ROI through strategic site, patient, data and risk management in the regulated markets
â€¢ Identify the data management, CMC supply chain, operational requirements and CRO
infrastructure in India and South Asia
â€¢ Gaining insights on future forwards of clinical trials and valuing its potential
â€¢ Discover how to improve your supplier-client relationships
â€¢ Complete trials on schedule and budget by learning to overcome hurdles in
â€¢ What are the issues with off-shoring trials to countries such as India & South Asia?
What are the ways to overcome them?
â€¢ Explore innovative strategies for outsourcing, what you should be looking for in a CRO?
â€¢ Working with limited budget to ensure on time study completion
â€¢ Escalating patient recruitment and improving patient retention to save cost and reduce
â€¢ Maximizing trials results through overseas multinational/multi-centric trials
â€¢ Avoiding potential pitfalls of trials agreement
â€¢ Motivating and managing clinical project teams to improve timeline and progress